Home Compare FME.DE vs GALE.SW
Stock Comparison · Comparison

Fresenius Medical Care vs Galenica: Which Stock Looks Stronger in 2026?

Fresenius Medical Care holds the cleaner structural position, with the lead spread across growth and valuation. Galenica still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Galenica, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Fresenius Medical Care, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The result is anchored in growth, but valuation also reinforces the same direction. The overall score gap is 15 points in favour of Fresenius Medical Care AG.

Trajectory Similarity
0.74
Similar
Peer-set rank: #12
within Fresenius Medical Care AG's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

Most of the shared profile comes through revenue stability and margin consistency.

Similarity drivers
revenue stabilitymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
FME.DE
Fresenius Medical Care AG
63
Peer-Score
Signal qualityMedium
vs
GALE.SW
Galenica AG
48
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: FME.DE vs GALE.SW Profitability 39 43 Stability 56 79 Valuation 86 54 Growth 71 17 FME.DE GALE.SW
Gap Ranking
#1 Growth +54
#2 Valuation +32
#3 Stability +23
#4 Profitability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for FME.DE and GALE.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer FME.DEGALE.SW Relative valuation Structural strength

Fresenius Medical Care AG looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Fresenius Medical Care AG ranks near the top of the group on growth; Galenica AG sits in the weaker half.
Valuation
On valuation, the same pattern holds: both are strong, but Fresenius Medical Care AG still leads clearly.
Growth — Dominant Gap
FME.DE
71
GALE.SW
17
Gap+54in favour of FME.DE

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Galenica AG still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

The lead is built on both growth and valuation — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the FME.DE vs GALE.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how FME.DE and GALE.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.